Find out how developments in AlphaFold 3, alongside new predictive models, are changing approaches to drug discovery and ...

Computational drug discovery and design integrates advanced computer‐aided methodologies with chemical and biological insights to accelerate the identification and optimisation of therapeutic agents.

Powered by PandaOmics, Insilico’s proprietary generative biology AI platform, the joint R&D team comprising Insilico Medicine and Sanofi colleagues focused on highly novel targets known to be ...

Southwest Research Institute scientists and engineers have developed a custom large language model (LLM) to accelerate drug design and discovery. Subscribe to our newsletter for the latest sci-tech ...

About 30% of all respiratory tract infections are caused by coronaviruses, leading to widespread illnesses and, in some cases, to epidemic and even pandemic outbreaks, as we experienced with the COVID ...

G protein-coupled receptors (GPCRs) represent the largest family of membrane proteins and one of the most successful therapeutic targets in modern medicine, with approximately 34% of FDA-approved ...

A team of chemists has unveiled a novel method to simplify the synthesis of piperidines, a key structural component in many pharmaceuticals. The study combines biocatalytic carbon-hydrogen oxidation ...

SwRI developed a large language model called Generative Approaches for Molecular Encodings (GAMES) to generate Simplified Molecular Input Line Entry System (SMILES) strings, which offer a text-based ...

The three-story Drug Discovery Facility is designed to promote the discovery, design and development of new drugs through an innovative architecture that encourages collaborations in chemistry, ...

GLASGOW, Scotland--(BUSINESS WIRE)--Chemify, a deep tech chemical science company combining chemistry, robotics and AI at scale to digitally design, discover and make new molecules, announced today ...

Even though AI-designed drugs aren’t yet a household term for FDA-approved, commercially available therapies, they are a reality in clinical development pipelines. In spring 2024, CBER reported more ...

TOKYO--(BUSINESS WIRE)--Elix, Inc. (CEO: Shinya Yuki / Headquarters: Tokyo; hereinafter “Elix”) is pleased to announce that its AI drug discovery platform, Elix ...